Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 15, Number 3—March 2009
Letter

Helicobacter pylori Infection in Patients Undergoing Upper Endoscopy, Republic of Georgia

Nato TarkhashviliComments to Author , Rusudan Beriashvili, Neli Chakvetadze, Maia Moistsrapishvili, Maia Chokheli, Merab Sikharulidze, Lile Malania, Nato Abazashvili, Ekaterine Jhorjholiani, Marina Chubinidze, Nanuli Ninashvili, Tamar Zardiashvili, Ucha Gabunia, Dimitri Kordzaia, Paata Imnadze, Jeremy Sobel, and Jeannette Guarner
Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA (N. Tarkhashvili, J. Sobel); National Center for Disease Control and Medical Statistics, Tbilisi, Republic of Georgia (R. Beriashvili, N. Chakvetadze, M. Moistsrapishvili, M. Chokheli, M. Sikharulidze, L. Malania, N. Abazashvili, E. Jhorjholiani, M. Chubinidze, N. Ninashvili, T. Zardiashvili, U. Gabunia, D. Kordzaia, P. Imnadze); Emory University School of Medicine, Atlanta (J. Guarner); Children's Healthcare of Atlanta, Atlanta (J. Guarner)

Main Article

Table

Histopathologic characteristics assessed in the biopsy specimens of study participants, by final pathologic diagnosis, Republic of Georgia, 2003–2005.

Final pathologic diagnosis No. Heliobacter pylori positive/no. tested (%), n = 82 No. with acute inflammation/no. tested (%), n = 90 No. with chronic inflammation/no. tested (%), n = 89 No. with intestinal metaplasia/no. tested (%), n = 84 No. with glandular atrophy/no. tested (%), n = 68
Gastritis* (n = 62) 45/58 (78) 55/62 (89) 55/62 (89) 19/60 (32) 10/50 (20)
Peptic ulcer (n = 14) 7/12 (58) 14/14 (100) 12/13 (92) 5/13 (38) 1/10 (10)
Dysplasia or cancer (n = 14) 7/12 (58) 12/14 (86) 10/14 (71) 5/11 (45) 0/8 (0)
Total (n = 90) 59/82 (72) 81/90 (90) 77/89 (87) 29/84 (35) 11/68 (16)

*According to the Updated Sydney Classification System for Gastritis (7).

Main Article

References
  1. Suerbaum  S, Michetti  P. Helicobacter pylori infections. N Engl J Med. 2002;347:1175–86. DOIPubMedGoogle Scholar
  2. Lacy  BE, Rosemore  J. Helicobacter pylori: ulcers and more: the beginning of an era. J Nutr. 2001;131:2789S–93S.PubMedGoogle Scholar
  3. Makola  D, Peura  D, Crowe  S. Helicobacter pylori infection and related gastrointestinal diseases. J Clin Gastroenterol. 2007;41:548–58. DOIPubMedGoogle Scholar
  4. Duck  WM, Sobel  J, Pruckler  JM, Song  Q, Swerdlow  D, Friedman  C, Antimicrobial resistance incidence and risk factors among Helicobacter pylori–infected persons, United States. Emerg Infect Dis. 2004;10:1088–94.PubMedGoogle Scholar
  5. Kretsinger  K, Sobel  J, Tarkhashvili  N, Chakvetadze  N, Moistrafishvili  M, Sikharulidze  M, Helicobacter pylori, Republic of Georgia. Emerg Infect Dis. 2005;11:780–1.PubMedGoogle Scholar
  6. Olivares  A, Buadze  M, Kutubidze  T, Lobjanidze  M, Labauri  L, Kutubidze  R, Prevalence of Helicobacter pylori in Georgian patients with dyspepsia. Helicobacter. 2006;11:81–5. DOIPubMedGoogle Scholar
  7. Dixon  MF, Genta  RM, Yardley  JH, Correa  P. Classification and grading of gastritis: the updated Sydney system. Am J Surg Pathol. 1996;20:1161–81. DOIPubMedGoogle Scholar
  8. Muñoz  N, Kato  I, Peraza  S, Lopez  G, Carrillo  E, Ramirez  H, Prevalence of precancerous lesions of the stomach in Venezuela. Cancer Epidemiol Biomarkers Prev. 1996;5:41–6.PubMedGoogle Scholar
  9. Correa  P, Haenszel  W, Cuello  C, Zavala  D, Fontham  E, Zarama  G, Gastric precancerous process in a high risk population: cross-sectional studies. Cancer Res. 1990;50:4731–6.PubMedGoogle Scholar
  10. International Agency for Research on Cancer. Helicobacter pylori. In: IARC monograph on the evaluation of carcinogenic risks to humans. Vol. 61. Schistosomes, liver flukes and Helicobacter pylori. Lyon (France): International Agency for Research on Cancer; 1994. p. 177–240.

Main Article

Page created: December 07, 2010
Page updated: December 07, 2010
Page reviewed: December 07, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external